|
[1]
|
Barriers to tuberculosis treatment adherence in high-burden tuberculosis settings in Ashanti region, Ghana: a qualitative study from patient’s perspective
BMC Public Health,
2023
DOI:10.1186/s12889-023-16259-6
|
|
|
|
|
[2]
|
Potential for the Development of a New Generation of Aminoglycoside Antibiotics
Pharmaceutical Chemistry Journal,
2021
DOI:10.1007/s11094-021-02510-0
|
|
|
|
|
[3]
|
Drug repurposing approach against Mycobacterium tuberculosis Enoyl-[acyl-carrier-protein] reductase: insight from molecular dynamics simulations
Molecular Simulation,
2021
DOI:10.1080/08927022.2021.1968390
|
|
|
|
|
[4]
|
Potential for the Development of a New Generation of Aminoglycoside Antibiotics
Pharmaceutical Chemistry Journal,
2021
DOI:10.1007/s11094-021-02510-0
|
|
|
|
|
[5]
|
Green Approaches in Medicinal Chemistry for Sustainable Drug Design
2020
DOI:10.1016/B978-0-12-817592-7.00024-1
|
|
|
|
|
[6]
|
Trends of tuberculosis case detection, mortality and co-infection with HIV in Ghana: A retrospective cohort study
PLOS ONE,
2020
DOI:10.1371/journal.pone.0234878
|
|
|
|
|
[7]
|
Carbohydrates in Drug Discovery and Development
2020
DOI:10.1016/B978-0-12-816675-8.00013-0
|
|
|
|
|
[8]
|
A four-year trend in pulmonary bacteriologically confirmed tuberculosis case detection in Kampala-Uganda
BMC Pulmonary Medicine,
2019
DOI:10.1186/s12890-019-0853-3
|
|
|
|
|
[9]
|
Destination of aminoglycoside antibiotics in the ‘post-antibiotic era’
The Journal of Antibiotics,
2018
DOI:10.1038/ja.2017.117
|
|
|
|
|
[10]
|
Destination of aminoglycoside antibiotics in the ‘post-antibiotic era’
The Journal of Antibiotics,
2018
DOI:10.1038/ja.2017.117
|
|
|
|
|
[11]
|
Extended spectrum β‐lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern
Journal of Basic Microbiology,
2017
DOI:10.1002/jobm.201700008
|
|
|
|
|
[12]
|
Extended spectrum β-lactamase producing Escherichia coli
and Klebsiella pneumoniae
: critical tools for antibiotic resistance pattern
Journal of Basic Microbiology,
2017
DOI:10.1002/jobm.201700008
|
|
|
|
|
[13]
|
QSAR based therapeutic management of M. tuberculosis
Archives of Pharmacal Research,
2017
DOI:10.1007/s12272-017-0914-1
|
|
|
|
|
[14]
|
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
Med. Chem. Commun.,
2016
DOI:10.1039/C5MD00344J
|
|
|
|
|
[15]
|
Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: A Five-Year Retrospective Study
PLOS ONE,
2016
DOI:10.1371/journal.pone.0150560
|
|
|
|
|
[16]
|
Defining multidrug-resistant tuberculosis: correlating GenoType MTBDR plus assay results with minimum inhibitory concentrations
Diagnostic Microbiology and Infectious Disease,
2015
DOI:10.1016/j.diagmicrobio.2015.01.009
|
|
|
|
|
[17]
|
Multiple drug-susceptibility screening in Mycobacterium bovis: new nucleotide polymorphisms in the embB gene among ethambutol susceptible strains
International Journal of Infectious Diseases,
2015
DOI:10.1016/j.ijid.2014.12.043
|
|
|
|
|
[18]
|
Study of mechanism of interaction of truncated isoniazid–nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach
International Journal of Mycobacteriology,
2015
DOI:10.1016/j.ijmyco.2015.06.006
|
|
|
|
|
[19]
|
Evaluation of Pyrosequencing for Detecting Extensively Drug-Resistant Mycobacterium tuberculosis among Clinical Isolates from Four High-Burden Countries
Antimicrobial Agents and Chemotherapy,
2015
DOI:10.1128/AAC.03614-14
|
|
|
|
|
[20]
|
Stratifying low level Isoniazid resistance using additional intermediate drug concentration
International Journal of Mycobacteriology,
2014
DOI:10.1016/j.ijmyco.2014.02.001
|
|
|
|
|
[21]
|
Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug
International Journal of Mycobacteriology,
2014
DOI:10.1016/j.ijmyco.2014.08.003
|
|
|
|